Core Insights - Bayer's oral contraceptive Youshu Yue in a 84-tablet pack has successfully completed import customs clearance and is launched on Alibaba Health, aiming to enhance medication convenience and adherence for women's health management [1][3] - The launch coincides with the initiation of the "Consensus on Clinical Application of Combined Oral Contraceptives in China," which emphasizes the importance of medication adherence in disease management for women [3] Group 1: Product Launch and Features - Youshu Yue is designed to cover a complete three-month medication cycle, addressing the actual needs of long-term health management for women [1] - The product is a short-acting oral contraceptive approved in China since December 2014, featuring a "24+4" dosing regimen, which includes 24 active tablets and 4 inactive tablets [3] - It is indicated for contraception and treatment of moderate acne in females aged 14 and above without known contraindications for oral contraceptives [3] Group 2: Market Context and Challenges - The usage rate of combined oral contraceptives (COCs) among women of childbearing age in China is notably low, primarily due to fears of hormonal medications and insufficient understanding of COCs [3] - The lack of awareness leads to underutilization of COCs, which can provide both contraceptive and non-contraceptive health benefits [3] Group 3: Service and Distribution - Alibaba Health serves as a platform for the launch, providing a comprehensive online healthcare service system, including professional pharmacist reviews and medication guidance [4] - The platform addresses the inconvenience of purchasing medications due to time and geographical limitations, ensuring continuity of treatment through efficient nationwide delivery [4]